General Provisions - The purpose of the guidelines is to improve management efficiency and governance structure of Guangzhou Kingmed Diagnostics Group Co., Ltd, clarifying the responsibilities of the general manager and ensuring the company's stable development [2][4]. Qualifications - The general manager and senior management must possess integrity, diligence, strong sense of responsibility, and teamwork spirit [4]. - Candidates should have substantial management experience, economic theory knowledge, and strong management capabilities [4]. - Familiarity with industry operations and relevant national policies is required [4]. Appointment and Dismissal Procedures - The general manager is appointed or dismissed by the board of directors, with a term of three years, which can be renewed [6][11]. - The general manager can resign before the term ends, following procedures outlined in the labor contract [6]. Powers and Duties - The general manager is responsible for the company's operations, implementing board resolutions, and reporting to the board [8]. - Responsibilities include organizing annual plans, drafting internal management structures, and managing daily operational expenses [9]. - The general manager can hire and dismiss other management personnel, propose board meetings, and represent the company in contracts [9][12]. General Manager's Office Meeting System - The general manager's office meetings are held monthly to discuss major operational issues and execute board resolutions [21][22]. - Decisions made in these meetings are documented and must be reported to the board when necessary [25][26]. Reporting - The general manager must regularly report to the board on significant operational matters, with reports submitted biannually [36][38]. - Reports should cover the execution of board resolutions, operational plans, financial status, and major contracts [38]. Miscellaneous - The board is responsible for modifying these guidelines, which take effect upon board approval [40][41].

Group 1 - The board of directors of Shanghai Longyun Cultural Technology Group Co., Ltd. held its 18th meeting of the 6th board on August 22, 2025, with all 5 directors present, complying with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report, confirming that the report accurately reflects the company's operational status for the first half of 2025 without any false statements or omissions [2] - The board agreed to cancel the supervisory board and transfer its responsibilities to the audit committee, pending approval from the shareholders' meeting [2][3] Group 2 - The board approved amendments to the company's articles of association in accordance with the updated regulations from the Shanghai Stock Exchange [2][3] - The board also approved the revision of 14 governance documents to enhance the company's governance standards, with the first 6 items requiring shareholder approval [3] - A proposal was made to convene the second extraordinary shareholders' meeting of 2025, combining on-site and online voting methods to discuss the aforementioned proposals [3]

Group 1 - The company held its 31st meeting of the 4th Board of Directors on August 22, 2025, to discuss various governance matters [1] - The Board approved amendments to the company's Articles of Association and related rules to enhance corporate governance and compliance with legal requirements [2][3] - The Board agreed to seek shareholder approval for the issuance of H shares and listing on the Hong Kong Stock Exchange to further the company's international strategy [3][4] Group 2 - The proposed H share issuance will involve a maximum of 15% of the company's total share capital post-issuance, with an option for overallotment [6] - The issuance will be conducted through a public offering in Hong Kong and an international placement, with specific allocation strategies based on market conditions [5][7] - The company plans to use the proceeds from the H share issuance for network expansion, product development, brand building, and other strategic initiatives [9][10] Group 3 - The Board approved a plan for the company to transition into an overseas fundraising company following the successful issuance and listing of H shares [9][10] - The company will revise its internal governance documents to align with the new structure and regulatory requirements post-listing [18][24] - The Board proposed to establish a confidentiality and archival management system related to the overseas issuance and listing [27]

Core Viewpoint - Jiangsu Diao Microelectronics Co., Ltd. held its 13th meeting of the second Supervisory Board on August 22, 2025, where several key resolutions were passed regarding the company's financial reporting and governance structure [1][2][3] Group 1: Financial Reporting - The Supervisory Board unanimously approved the 2025 semi-annual report, confirming that the report's preparation and review processes comply with legal and regulatory requirements, and accurately reflect the company's financial status and operating results [1][2] - The report does not contain any false records, misleading statements, or significant omissions [1] Group 2: Fund Management - The Supervisory Board also approved the special report on the storage and use of raised funds for the first half of 2025, affirming compliance with relevant regulations and the company's fund management measures [2] - The company has stored and used the raised funds in a dedicated account, fulfilling information disclosure obligations without any unauthorized changes in fund usage or violations [2] Group 3: Governance Structure - A resolution was passed to cancel the Supervisory Board and transfer its powers to the Audit Committee of the Board of Directors, with corresponding amendments to the company's articles of association [3] - This resolution requires approval from the company's shareholders and aligns with various legal and regulatory guidelines [3]

证券代码：603686 证券简称：福龙马 公告编号：2025-045 福龙马集团股份有限公司 福龙马集团股份有限公司（以下简称"公司"）第六届 监事会第十四次会议于 2025 年 8 月 21 日 11:00 在公司本部 研发中心大楼三楼多功能会议室以现场方式召开。本次监事 会为定期会议，会议通知于 2025 年 8 月 11 日以电子邮件、 短信和微信方式发出。会议应出席监事 3 名，实际出席监事 事务代表列席了本次会议。会议由公司监事会主席沈家庆先 生主持。本次会议的召集召开符合有关法律、行政法规、部 门规章、规范性文件和《公司章程》的规定，会议决议合法、 有效。 二、监事会会议审议情况 会议审议通过了如下议案： （一）审议通过《关于公司 2025 年半年度报告及摘要 的议案》。 具体内容详见公司同日在上海证券交易所网站 第六届监事会第十四次会议决议公告 （www.sse.com.cn）披露的《福龙马 2025 年半年度报告》及 其摘要。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 经核查，监事会认为：1、公司 ...

Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 on September 8, 2025, at 1:00 PM in Chongqing [3] - The meeting will discuss several key proposals, including the reappointment of the auditing firm Tianjian and the cancellation of the supervisory board [4][8] - The company aims to enhance its corporate governance structure by revising its articles of association and related governance systems [9][10] Meeting Procedures - The meeting will be organized by the company's board office, and only authorized personnel will be allowed entry [2] - Shareholders wishing to speak must keep their comments concise, limited to three minutes, and relevant to the agenda [2] - Voting will be conducted through a combination of on-site and online methods, with each share carrying one vote [2][3] Proposals - Proposal 1: Reappointment of Tianjian Accounting Firm for the 2025 annual audit, with a total fee of 600,000 RMB for audit services [4][7] - Proposal 2: Cancellation of the supervisory board, transferring its responsibilities to the audit committee of the board [8][9] - Proposal 3: Revision and abolition of certain corporate governance systems to improve operational standards [9][10] Auditing Firm Details - Tianjian Accounting Firm has provided satisfactory services since its appointment, with a total revenue of 2.969 billion RMB and a securities business revenue of 1.465 billion RMB in the previous year [4][7] - The firm has faced some civil litigation in the past three years but has complied with all legal requirements and maintained its professional liability insurance [7][8] Governance Structure Changes - The company plans to amend its articles of association to reflect the cancellation of the supervisory board and to enhance its governance framework [9][10] - The proposed changes aim to streamline decision-making processes and improve compliance with regulatory standards [9][10]

Meeting Overview - The second meeting of the Supervisory Board of Jinkai (Liaoning) Life Science Co., Ltd. was held on August 22, 2025, with all three supervisors present, ensuring a valid meeting [1][2] Financial Reporting - The Supervisory Board reviewed and confirmed that the company's 2025 semi-annual report and its summary were prepared in accordance with relevant laws and regulations, accurately reflecting the company's financial status and operational results without any false records or omissions [1][2] Fund Management - The company adhered to the regulations regarding the management and use of raised funds, confirming that there were no violations in the storage and management of these funds [2][3] - The proposal to change the method of fund allocation from "loaning to subsidiaries" to "capital increase in subsidiaries" was deemed reasonable and beneficial for improving fund utilization efficiency and protecting shareholder interests [2][3] Cash Management - The use of part of the idle raised funds and self-owned funds for cash management was approved, ensuring it would not affect the investment projects or normal operations of the company [3][4] Capital Supplementation - The proposal to use part of the raised excess funds for permanent working capital supplementation was found to comply with regulations and not conflict with the investment plans [4] Corporate Governance - The revision of the company's articles of association was approved, aimed at optimizing governance and protecting the rights of investors, especially minority shareholders [4][5] Subsidiary Investment - The decision to use self-owned funds to increase capital in Kingchem Life Science LLC for the construction of Kingchem Laboratories Inc. was supported, aligning with the company's strategy to enhance international competitiveness and support global customer needs [5]

Core Viewpoint - The supervisory board of China Resources Boya Bio-Pharmaceutical Group Co., Ltd. confirmed the legality and compliance of the company's 2025 semi-annual report and related proposals, ensuring no misleading statements or omissions [1][2][3]. Group 1: Supervisory Board Meeting - The 12th meeting of the 8th supervisory board was held on August 21, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1]. - The supervisory board approved the procedures for reviewing the 2025 semi-annual report, affirming its authenticity and completeness [1][2]. Group 2: Profit Distribution Proposal - The supervisory board agreed that the profit distribution proposal for the 2025 semi-annual report complies with regulatory guidelines and the company's profit distribution policy [2]. - The proposal will be submitted for review at the company's first extraordinary general meeting of 2025 [2]. Group 3: Fund Management - The supervisory board expressed approval of the management of the special account for raised funds, confirming compliance with relevant regulations [2][3]. - The report on the storage and use of raised funds for the first half of 2025 was deemed accurate and complete by the supervisory board [2][3]. Group 4: Use of Bank Acceptance Bills - The supervisory board approved the proposal to use bank acceptance bills to pay for project funding and to replace the funds with raised capital [3].

第三届监事会第七次会议决议公告 证券代码：003013 证券简称：地铁设计 公告编号：2025-048 广州地铁设计研究院股份有限公司 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）上披露的《公 司 2025 年度半年度报告》，以及公司同日在《证券时报》、 《中国证券报》和巨潮 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 广州地铁设计研究院股份有限公司（以下简称"公司"）第三届监事会第七 次会议于 2025 年 8 月 22 日（星期五）以通讯表决方式召开，会议通知已于 2025 年 8 月 12 日以电子邮件的形式送达各位监事。本次会议应出席监事 5 人，实际 出席监事 5 人，无委托出席情况。会议由监事会主席方思源先生主持，本次会议 的召开和表决程序符合《公司法》等有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 二、监事会会议审议情况 与会监事以投票表决方式审议通过以下议案： （一）审议通过《关于 2025 年半年度报告及摘要的议案》 经核查，监事会认为：董事会编制和审核公司 2025 ...

Group 1 - The meeting of the fourth supervisory board of Qinhuangdao Tianqin Equipment Manufacturing Co., Ltd. was held on August 21, 2025, with all three supervisors present [1] - The supervisory board reviewed and approved the company's 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or significant omissions [1][2] - The supervisory board also confirmed that the management and use of the funds raised in the first half of 2025 comply with relevant regulations and the company's management measures [2]